These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31141524)

  • 21. Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study.
    Ismail NA; Omar SV; Joseph L; Govender N; Blows L; Ismail F; Koornhof H; Dreyer AW; Kaniga K; Ndjeka N
    EBioMedicine; 2018 Feb; 28():136-142. PubMed ID: 29337135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-genome sequencing reveals genetic signature of bedaquiline resistance in a clinical isolate of Mycobacterium tuberculosis.
    Chawla K; Martinez E; Kumar A; Shenoy VP; Sintchenko V
    J Glob Antimicrob Resist; 2018 Dec; 15():103-104. PubMed ID: 30248414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
    Ismail N; Omar SV; Ismail NA; Peters RPH
    J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
    Salifu EY; Agoni C; Olotu FA; Soliman MES
    Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
    Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
    J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
    Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
    Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of Canonical and Noncanonical Genomic Variants following
    Ismail N; Dippenaar A; Warren RM; Peters RPH; Omar SV
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0136822. PubMed ID: 36892309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bedaquiline-Resistant Tuberculosis Associated with
    Omar SV; Ismail F; Ndjeka N; Kaniga K; Ismail NA
    N Engl J Med; 2022 Jan; 386(1):93-94. PubMed ID: 34986292
    [No Abstract]   [Full Text] [Related]  

  • 30. Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan.
    Ghodousi A; Rizvi AH; Baloch AQ; Ghafoor A; Khanzada FM; Qadir M; Borroni E; Trovato A; Tahseen S; Cirillo DM
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.
    Beckert P; Sanchez-Padilla E; Merker M; Dreyer V; Kohl TA; Utpatel C; Köser CU; Barilar I; Ismail N; Omar SV; Klopper M; Warren RM; Hoffmann H; Maphalala G; Ardizzoni E; de Jong BC; Kerschberger B; Schramm B; Andres S; Kranzer K; Maurer FP; Bonnet M; Niemann S
    Genome Med; 2020 Nov; 12(1):104. PubMed ID: 33239092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease.
    Alexander DC; Vasireddy R; Vasireddy S; Philley JV; Brown-Elliott BA; Perry BJ; Griffith DE; Benwill JL; Cameron AD; Wallace RJ
    J Clin Microbiol; 2017 Feb; 55(2):574-584. PubMed ID: 27927925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Prevalence of Bedaquiline Resistance in Treatment-Naive Tuberculosis Patients and Verapamil Effectiveness.
    Ghajavand H; Kargarpour Kamakoli M; Khanipour S; Pourazar Dizaji S; Masoumi M; Rahimi Jamnani F; Fateh A; Siadat SD; Vaziri F
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.
    Yang JS; Kim KJ; Choi H; Lee SH
    Ann Lab Med; 2018 Nov; 38(6):563-568. PubMed ID: 30027700
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
    Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant
    Xu J; Converse PJ; Upton AM; Mdluli K; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526488
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of
    Sarathy JP; Ragunathan P; Shin J; Cooper CB; Upton AM; Grüber G; Dick T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for
    Sivaramakrishnan G; Subramanyam B; Kumar MP; Golla R; Tripathy SP; Mondal R
    Int J Mycobacteriol; 2019; 8(4):329-332. PubMed ID: 31793501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.